nivolumab,argx-113,ipilimumab
ono Pharmaceuticals,bms,argenx
['adapt trial', 'tnbc', 'bellini', 'breast']
#esmo22 proffered abstracts #breastcancer data trial extend ai; gim trial longer results to dose dense and to add 5 fu; adapt trial and adaptcycle to add ofs ai in premenopausal women; bellini trial a window opportunity to consider #neoadjuvant io based tils in #tnbc 
Medical Oncology at https://t.co/hCfxKt8kbP and https://t.co/YeizvuTGR3 Opinions are my own.